Atlas Trials

Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

Clinical trial NCT02836925 · COMPLETED

Trial details

NCT number
NCT02836925
Sponsor
Fondazione Italiana Linfomi - ETS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Indolent B-cell LymphomaHepatitis C
Start date
2016-03-01
Primary completion
2020-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.